Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Estee Lauder
EL
|
+$664M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$657M |
| 3 |
UnitedHealth
UNH
|
+$644M |
| 4 |
AbbVie
ABBV
|
+$544M |
| 5 |
PayPal
PYPL
|
+$482M |
Top Sells
| 1 |
O'Reilly Automotive
ORLY
|
+$559M |
| 2 |
SHPG
Shire pic
SHPG
|
+$454M |
| 3 |
Amazon
AMZN
|
+$448M |
| 4 |
Alibaba
BABA
|
+$423M |
| 5 |
Ulta Beauty
ULTA
|
+$412M |
Sector Composition
| 1 | Technology | 21.02% |
| 2 | Healthcare | 15.35% |
| 3 | Consumer Discretionary | 14.87% |
| 4 | Communication Services | 13.03% |
| 5 | Financials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ovintiv
OVV
$10.7B
| $13.3M | 0.01% |
+226,076
| New | +$13.3M |
|
452
Baker Hughes
BKR
$44.8B
| $13.3M | 0.01% |
+362,997
| New | +$13.3M |
|
|
EVHC
453
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $13.2M | 0.01% |
294,736
-63,752
| -18% | -$2.87M |
|
|
OA
454
DELISTED
Orbital ATK, Inc.
OA
| $13M | 0.01% |
97,831
-157,698
| -62% | -$21M |
|
|
PARA
455
DELISTED
Paramount Global Class B
PARA
| $12.9M | 0.01% |
+221,792
| New | +$12.9M |
|
456
Independence Realty Trust
IRT
$4.18B
| $12.7M | 0.01% |
+1,250,000
| New | +$12.7M |
|
457
Evolent Health
EVH
$1.16B
| $12.5M | 0.01% |
+704,007
| New | +$12.5M |
|
|
SEI
458
Solaris Energy Infrastructure, Inc.
SEI
$1.11B
| $12.3M | 0.01% |
705,620
-59,147
| -8% | -$1.03M |
|
459
Freeport-McMoran
FCX
$63B
| $12.3M | 0.01% |
873,558
-49,461
| -5% | -$694K |
|
460
Ocular Therapeutix
OCUL
$2.22B
| $12.2M | 0.01% |
1,974,636
-10,860
| -0.5% | -$67.1K |
|
461
FibroGen
FGEN
$46.4M
| $12.1M | 0.01% |
+9,000
| New | +$12.1M |
|
462
NCS Multistage Holdings
NCSM
$118M
| $12.1M | 0.01% |
25,087
+2,154
| +9% | +$1.04M |
|
463
ProQR Therapeutics
PRQR
$245M
| $11.9M | 0.01% |
2,457,360
-15,248
| -0.6% | -$74K |
|
464
Hain Celestial
HAIN
$172M
| $11.8M | 0.01% |
286,629
-1,683,781
| -85% | -$69.3M |
|
465
Commault Systems
CVLT
$8.23B
| $11.8M | 0.01% |
193,375
+450
| +0.2% | +$27.4K |
|
|
RICE
466
DELISTED
Rice Energy Inc.
RICE
| $11.7M | 0.01% |
402,961
-37,947
| -9% | -$1.1M |
|
|
CIM
467
Chimera Investment
CIM
$1.18B
| $11.4M | 0.01% |
201,324
| – | – |
|
468
e.l.f. Beauty
ELF
$7.88B
| $11.2M | 0.01% |
498,725
-218,069
| -30% | -$4.92M |
|
469
Syndax Pharmaceuticals
SNDX
$1.37B
| $11.1M | 0.01% |
951,898
-1,964
| -0.2% | -$23K |
|
470
Agios Pharmaceuticals
AGIO
$2.1B
| $11.1M | 0.01% |
166,065
-390
| -0.2% | -$26K |
|
471
MGP Ingredients
MGPI
$605M
| $10.9M | 0.01% |
+179,455
| New | +$10.9M |
|
472
BP
BP
$87.8B
| $10.8M | 0.01% |
+312,509
| New | +$10.8M |
|
473
Philips
PHG
$26.7B
| $10.7M | 0.01% |
+329,651
| New | +$10.7M |
|
|
NS
474
DELISTED
NuStar Energy L.P.
NS
| $10.7M | 0.01% |
262,565
-36
| -0% | -$1.46K |
|
|
TRHC
475
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.7M | 0.01% |
398,455
-664
| -0.2% | -$17.8K |
|